Target of rapamycin (TOR) inhibition in renal transplantation: Clinical uses in various populations. Introduction. [electronic resource]
- American journal of kidney diseases : the official journal of the National Kidney Foundation Oct 2001
- S1-2 p. digital
Publication Type: Journal Article
1523-6838
Black People--genetics Calcineurin Inhibitors Graft Rejection--prevention & control Graft Survival--drug effects Humans Immunosuppressive Agents--pharmacology Kidney Transplantation--immunology Sirolimus--pharmacology Treatment Outcome